APA

Berns E. M. J. J., Klijn J. G. M., Look M. P., Grebenchtchikov N., Vossen R., Peters H., Geurts-Moespot A., Portengen H., van Staveren I. L., Meijer-van Gelder M. E., Bakker B., Sweep F. C. G. J. & Foekens J. A. (20040120). Combined vascular endothelial growth factor and TP53 status predicts poor response to tamoxifen therapy in estrogen receptor-positive advanced breast cancer. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Chicago

Berns Els M J J, Klijn Jan G M, Look Maxime P, Grebenchtchikov Nicolai, Vossen Rolf, Peters Harry, Geurts-Moespot Anneke, Portengen Henk, van Staveren Iris L, Meijer-van Gelder Marion E, Bakker Bert, Sweep Fred C G J and Foekens John A. 20040120. Combined vascular endothelial growth factor and TP53 status predicts poor response to tamoxifen therapy in estrogen receptor-positive advanced breast cancer. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Harvard

Berns E. M. J. J., Klijn J. G. M., Look M. P., Grebenchtchikov N., Vossen R., Peters H., Geurts-Moespot A., Portengen H., van Staveren I. L., Meijer-van Gelder M. E., Bakker B., Sweep F. C. G. J. and Foekens J. A. (20040120). Combined vascular endothelial growth factor and TP53 status predicts poor response to tamoxifen therapy in estrogen receptor-positive advanced breast cancer. : Clinical cancer research : an official journal of the American Association for Cancer Research.

MLA

Berns Els M J J, Klijn Jan G M, Look Maxime P, Grebenchtchikov Nicolai, Vossen Rolf, Peters Harry, Geurts-Moespot Anneke, Portengen Henk, van Staveren Iris L, Meijer-van Gelder Marion E, Bakker Bert, Sweep Fred C G J and Foekens John A. Combined vascular endothelial growth factor and TP53 status predicts poor response to tamoxifen therapy in estrogen receptor-positive advanced breast cancer. : Clinical cancer research : an official journal of the American Association for Cancer Research. 20040120.